Geneva - Shares in UBS tumbled badly Friday, a day after the United States authorities issued a lawsuit against the bank demanding that it hand over about 52,000 names of clients.
At one point in early morning trading the stocks dropped 17 per cent, and ultimately closed the day at 11 Swiss francs, down 14 per cent from its opening price.
The bank, the largest in Switzerland, said it would challenge the US lawsuit.
Noida based chemicals and drug maker Jubilant Organosys failed to witness good response to its buy back offer for all its outstanding foreign currency convertible bonds
(FCCBs) worth $241 million. The firm said, in a filing before Bombay Stock Exchange, that it would buy FCCBs worth $3 million due in 2010 with total cash of $2.55 million.
The firm received bids worth $48 million only for buy back shares via FCCB tender offer.